Department of Anesthesiology and Pain Medicine, Affiliated Hospital of Jiaxing University, Jiaxing 314001, Zhejiang, China.
Department of Central Laboratory, Affiliated Hospital of Jiaxing University, Jiaxing 314001, Zhejiang, China.
Pain Res Manag. 2022 Jun 10;2022:2180214. doi: 10.1155/2022/2180214. eCollection 2022.
This study aims at investigating the internal heat acupuncture (IHA) combined with the high-voltage long-duration pulsed radiofrequency (PRF) therapeutic effect on subacute postherpetic neuralgia (PHN).
This retrospective study comprised 81 cases with PHN. They were divided into three groups: IHA combined with the high-voltage long-duration PRF group (IHA-PRF), intradermal injection combined with the high-voltage long-duration PRF group (II-PRF), and the high-voltage long-duration PRF group. The pain numerical rating score (NRS), IL-6, Gal-3, and blood glucose levels were recorded before and after treatment.
Compared with before treatment, NRS scores of the three groups were all decreased at each time point. NRS scores of the IHA-PRF group patients decreased significantly in comparison to the PRF group at 1, 4, 8, and 12 weeks following treatment, while group II-PRF only decreased significantly at one week following treatment. Compared with groups II-PRF and PRF, respectively, IL-6 and Gal-3 levels in plasma of patients in group IHA-PRF were significantly decreased at 4 and 12 weeks after treatment. The effective rate of group IHA-PRF was 88.9%, which was considerably more than the other groups, II-PRF (63.0%) and PRF (63.0%). Compared with group II-PRF, patients' blood glucose levels in IHA-PRF and PRF groups significantly decreased three days and one week after treatment.
Internal heat acupuncture combined with high-voltage long-duration pulsed radiofrequency has a satisfactory therapeutic effect on subacute PHN and has no obvious adverse reactions, which is especially suitable for patients with poor blood glucose control.
本研究旨在探讨内热针(IHA)联合高压长时程脉冲射频(PRF)治疗亚急性带状疱疹后神经痛(PHN)的疗效。
本回顾性研究纳入 81 例 PHN 患者,分为 IHA-PRF 组(IHA 联合高压长时程 PRF)、II-PRF 组(皮内注射联合高压长时程 PRF)和 PRF 组,记录治疗前后的疼痛数字评分量表(NRS)评分、白细胞介素 6(IL-6)、半乳糖凝集素 3(Gal-3)和血糖水平。
与治疗前相比,三组 NRS 评分均在各时间点降低,治疗后 1、4、8、12 周时 IHA-PRF 组患者的 NRS 评分均显著低于 PRF 组,而 II-PRF 组仅在治疗后 1 周时显著降低;与 II-PRF 组和 PRF 组相比,IHA-PRF 组患者血浆中 IL-6 和 Gal-3 水平在治疗后 4 和 12 周时显著降低;IHA-PRF 组的有效率为 88.9%,明显高于 II-PRF 组(63.0%)和 PRF 组(63.0%);与 II-PRF 组相比,IHA-PRF 组和 PRF 组患者的血糖水平在治疗后 3 天和 1 周时显著降低。
内热针联合高压长时程脉冲射频治疗亚急性 PHN 疗效满意,无明显不良反应,尤其适用于血糖控制不佳的患者。